These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34750098)

  • 21. Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers.
    Kaczkowski B; Tanaka Y; Kawaji H; Sandelin A; Andersson R; Itoh M; Lassmann T; Hayashizaki Y; Carninci P; Forrest AR;
    Cancer Res; 2016 Jan; 76(2):216-26. PubMed ID: 26552699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear receptors in oral cancer-Emerging players in tumorigenesis.
    Gangwar SK; Kumar A; Jose S; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Cancer Lett; 2022 Jun; 536():215666. PubMed ID: 35364221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic profiling in nuclear receptor-mediated toxicity.
    Woods CG; Heuvel JP; Rusyn I
    Toxicol Pathol; 2007 Jun; 35(4):474-94. PubMed ID: 17562482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear hormone receptor signaling in amphioxus.
    Schubert M; Brunet F; Paris M; Bertrand S; Benoit G; Laudet V
    Dev Genes Evol; 2008 Dec; 218(11-12):651-65. PubMed ID: 18815806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon.
    Pons G; Gallo-Oller G; Navarro N; Zarzosa P; Sansa-Girona J; García-Gilabert L; Magdaleno A; Segura MF; Sánchez de Toledo J; Gallego S; Moreno L; Roma J
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide identification of nuclear receptor (NR) superfamily genes in the copepod Tigriopus japonicus.
    Hwang DS; Lee BY; Kim HS; Lee MC; Kyung DH; Om AS; Rhee JS; Lee JS
    BMC Genomics; 2014 Nov; 15(1):993. PubMed ID: 25407996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic illumination of druggable genes in cancer genomes.
    Jiang J; Yuan J; Hu Z; Zhang Y; Zhang T; Xu M; Long M; Fan Y; Tanyi JL; Montone KT; Tavana O; Vonderheide RH; Chan HM; Hu X; Zhang L
    Cell Rep; 2022 Feb; 38(8):110400. PubMed ID: 35196490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes.
    Liu C; Zhao J; Lu W; Dai Y; Hockings J; Zhou Y; Nussinov R; Eng C; Cheng F
    PLoS Comput Biol; 2020 Feb; 16(2):e1007701. PubMed ID: 32101536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear receptors in Bombyx mori: insights into genomic structure and developmental expression.
    Cheng D; Xia Q; Duan J; Wei L; Huang C; Li Z; Wang G; Xiang Z
    Insect Biochem Mol Biol; 2008 Dec; 38(12):1130-7. PubMed ID: 18992339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide identification, evolution and expression analysis of nuclear receptor superfamily in Nile tilapia, Oreochromis niloticus.
    Cheng YY; Tao WJ; Chen JL; Sun LN; Zhou LY; Song Q; Wang DS
    Gene; 2015 Sep; 569(1):141-52. PubMed ID: 26024593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-specific integration of nuclear receptor function at the genome.
    Everett LJ; Lazar MA
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(5):615-29. PubMed ID: 23757177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening.
    Picco G; Chen ED; Alonso LG; Behan FM; Gonçalves E; Bignell G; Matchan A; Fu B; Banerjee R; Anderson E; Butler A; Benes CH; McDermott U; Dow D; Iorio F; Stronach E; Yang F; Yusa K; Saez-Rodriguez J; Garnett MJ
    Nat Commun; 2019 May; 10(1):2198. PubMed ID: 31097696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-cancer analyses of the nuclear receptor superfamily.
    Long MD; Campbell MJ
    Nucl Receptor Res; 2015 Dec; 2():. PubMed ID: 27200367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
    Liu H; Zhang B; Sun Z
    Cancer Commun (Lond); 2020 Jan; 40(1):43-59. PubMed ID: 32067422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear receptor expression in human differentiated thyroid tumors.
    Mond M; Alexiadis M; Eriksson N; Davis MJ; Muscat GE; Fuller PJ; Gilfillan C
    Thyroid; 2014 Jun; 24(6):1000-11. PubMed ID: 24559275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Nuclear Receptors in Prostate Cancer.
    Shiota M; Fujimoto N; Kashiwagi E; Eto M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31212954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of nuclear receptor and cofactor expression in breast cancer cell lines.
    Vienonen A; Miettinen S; Manninen T; Altucci L; Wilhelm E; Ylikomi T
    Eur J Endocrinol; 2003 Apr; 148(4):469-79. PubMed ID: 12656669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A conserved surface on the ligand binding domain of nuclear receptors for allosteric control.
    Buzón V; Carbó LR; Estruch SB; Fletterick RJ; Estébanez-Perpiñá E
    Mol Cell Endocrinol; 2012 Jan; 348(2):394-402. PubMed ID: 21878368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
    Varešlija D; Priedigkeit N; Fagan A; Purcell S; Cosgrove N; O'Halloran PJ; Ward E; Cocchiglia S; Hartmaier R; Castro CA; Zhu L; Tseng GC; Lucas PC; Puhalla SL; Brufsky AM; Hamilton RL; Mathew A; Leone JP; Basudan A; Hudson L; Dwyer R; Das S; O'Connor DP; Buckley PG; Farrell M; Hill ADK; Oesterreich S; Lee AV; Young LS
    J Natl Cancer Inst; 2019 Apr; 111(4):388-398. PubMed ID: 29961873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.